Company · CIK 1809616
Universe Pharmaceuticals INC
| CIK | 1809616 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | F4 |
| Business address | China |
| Listed | UPC (Nasdaq) |
| First annual or quarterly report | 2022-01-31 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-299191 | 2026-09-29 | 2026-10-09 | 2 | |
| 333-268028 | 2022-10-27 | 2024-12-09 | 3 | |
| 333-278914 | 2024-04-24 | 2024-06-25 | 4 | |
| 333-248067 | 2020-08-17 | 2021-03-24 | 7 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-10-09 | EFFECTDeclared effective | 333-299191 | 9999999995-26-003207 |
| 2026-09-29 | F-3Shelf registered | 333-299191 | 0001213900-26-104659 |
| 2024-12-09 | 424B5Shelf takedown | 333-268028 | 0001213900-24-106939 |
| 2024-06-25 | 424B4Final prospectus | 333-278914 | 0001213900-24-055732 |
| 2024-06-07 | EFFECTDeclared effective | 333-278914 | 9999999995-24-001783 |
| 2024-05-14 | F-1/AAmendment | 333-278914 | 0001213900-24-042922 |
| 2024-04-24 | F-1Registration filed | 333-278914 | 0001213900-24-035858 |
| 2022-11-15 | EFFECTDeclared effective | 333-268028 | 9999999995-22-003304 |
| 2022-10-27 | F-3Shelf registered | 333-268028 | 0001213900-22-066745 |
| 2021-03-24 | 424B4Final prospectus | 333-248067 | 0001213900-21-017519 |
| 2021-03-22 | EFFECTDeclared effective | 333-248067 | 9999999995-21-001048 |
| 2021-03-10 | F-1/AAmendment | 333-248067 | 0001213900-21-014541 |
| 2021-02-24 | F-1/AAmendment | 333-248067 | 0001213900-21-011334 |
| 2020-12-02 | F-1/AAmendment | 333-248067 | 0001213900-20-040413 |
| 2020-11-17 | F-1/AAmendment | 333-248067 | 0001213900-20-037560 |
| 2020-08-17 | F-1Registration filed | 333-248067 | 0001213900-20-022480 |
| 2020-04-24 | DRSDraft made public | 377-03139 | 0001213900-20-010024 |